SCHEMBL4682963

SCHEMBL4682963

CCC(C1CC(n2c(=O)[nH]c3cc(Cl)ccc32)CCN1C(=O)O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 7/20 0.51
▸ DRD2 P14416 3/20 0.49
▸ HTR1A P08908 2/20 0.49
▸ ADRA2A P08913 2/20 0.49
▸ HTR2A P28223 2/20 0.49
▸ SLC6A4 P31645 2/20 0.49
▸ DRD3 P35462 2/20 0.49
▸ PLD1 Q13393 7/20 0.48
▸ PLD2 O14939 6/20 0.48
▸ USP2 O75604 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ OPRM1 P35372 4/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ SLC22A2 O15244 1/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ GMNN O75496 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3803735 0.90 OPRM1 (0.49) CHRM1PLD1PLD2CYP2D6OPRM1
SCHEMBL4682974 0.85 CHRM1 (0.52) CHRM1DRD2HTR1AADRA2AHTR2A
SCHEMBL4682975 0.85 CHRM1 (0.52) CHRM1DRD2HTR1AADRA2AHTR2A
SCHEMBL1840394 0.84 OPRM1 (0.55) CHRM1DRD2DRD3PLD1PLD2
SCHEMBL1833748 0.83 OPRM1 (0.42) CHRM1CYP2D6OPRM1CYP3A4OPRK1
SCHEMBL1839221 0.82 OPRM1 (0.53) DRD2HTR1AADRA2AHTR2ASLC6A4
SCHEMBL1835996 0.82 OPRM1 (0.54) CHRM1DRD2HTR1AADRA2AHTR2A
SCHEMBL1833800 0.81 BCHE (0.45) CHRM1DRD2CYP2D6OPRM1OPRK1
SCHEMBL1833680 0.80 OPRM1 (0.51) CHRM1PLD1PLD2CYP2D6OPRM1
SCHEMBL4682970 0.78 CHRM1 (0.52) CHRM1DRD2HTR1AADRA2AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback